284 related articles for article (PubMed ID: 19567677)
1. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
2. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
3. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
5. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
6. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
[TBL] [Abstract][Full Text] [Related]
8. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
[TBL] [Abstract][Full Text] [Related]
9. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
11. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of nanog by OCT4 and SOX2.
Rodda DJ; Chew JL; Lim LH; Loh YH; Wang B; Ng HH; Robson P
J Biol Chem; 2005 Jul; 280(26):24731-7. PubMed ID: 15860457
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
[TBL] [Abstract][Full Text] [Related]
14. The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs.
Lim LS; Hong FH; Kunarso G; Stanton LW
Stem Cells; 2010 Nov; 28(11):1961-9. PubMed ID: 20872845
[TBL] [Abstract][Full Text] [Related]
15. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors.
Hart AH; Hartley L; Parker K; Ibrahim M; Looijenga LH; Pauchnik M; Chow CW; Robb L
Cancer; 2005 Nov; 104(10):2092-8. PubMed ID: 16206293
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide gain-of-function screen identifies novel regulators of pluripotency.
Abujarour R; Efe J; Ding S
Stem Cells; 2010 Sep; 28(9):1487-97. PubMed ID: 20629179
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.
Tan Y; Xie Z; Ding M; Wang Z; Yu Q; Meng L; Zhu H; Huang X; Yu L; Meng X; Chen Y
Stem Cells Dev; 2010 Sep; 19(9):1365-74. PubMed ID: 19916800
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation.
Tay Y; Zhang J; Thomson AM; Lim B; Rigoutsos I
Nature; 2008 Oct; 455(7216):1124-8. PubMed ID: 18806776
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
